Therapy Areas: Infectious Diseases
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
20 June 2025 - Immuno Cure BioTech, a clinical-stage biotechnology group based in Hong Kong Science Park, announced on Thursday its upcoming collaboration with US-based PharmaJet to evaluate the safet...
Oxurion signs LOI to acquire majority stake in preclinical microbiology CRO
19 June 2025 - Belgian biopharmaceutical company Oxurion NV (Euronext Brussels:OXUR) announced on Thursday that it has signed a letter of intent to acquire 70% of a preclinical microbiology contract r...
bioMérieux acquires Day Zero Diagnostics assets to expand rapid sequencing diagnostics
16 June 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Monday the acquisition of key assets from Day Zero Diagnostics, a US-based infectious disease diagnostics ...
EDX Medical and Spire Healthcare sign strategic diagnostic partnership agreement
16 June 2025 - EDX Medical Group plc (AQSE: EDX), a developer of digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular disease and infectious diseases,...
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
12 June 2025 - Critical care and infectious disease specialist Innoviva Specialty Therapeutics Inc (IST), a subsidiary of Innoviva Inc (Nasdaq:INVA), announced on Thursday that the US Food and Drug Ad...
Ondine's Steriwave proven effective against deadly Mucor fungus
9 June 2025 - Canadian life sciences company Ondine Biomedical Inc (AIM: OBI) on Monday reported new data from University College London (UCL) demonstrating the potent efficacy of its Steriwave photod...